Healthcare Triangle, Inc.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
HCTI$4.21-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Balance sheets
Interim Condensed Consolidated Balance Sheets
| September 30, · December 31, | |||
|---|---|---|---|
| Note | 2025 | 2024 | |
| (Unaudited) · (Audited) | |||
| Assets | |||
| Current assets | |||
| Cash and cash equivalents | $1,629 | $20 | |
| Accounts receivable, net | 3.1 | 2,441 | 1,110 |
| Due from affiliates | 3.6 | 3,502 | 497 |
| Other current assets | 3.5 | 370 | 322 |
| Total current assets | 7,942 | 1,949 | |
| Furniture and equipment, net | 3.2 | 5 | 12 |
| Goodwill and other intangibles, net | 3.3 | 5,891 | - |
| Total current and non-current assets | $13,838 | $1,961 | |
| Liabilities and stockholders’ equity (deficit) | |||
| Current liabilities | |||
| Accounts payable | 3.3 | $1,308 | $2,539 |
| Short term borrowing | 3.9 | 1,530 | 2,650 |
| Other current liabilities | 3.10 | 1,074 | 1,386 |
| Total current liabilities | 3,912 | 6,575 | |
| Long-term liabilities | |||
| Contingent consideration | 3.7 | 1,200 | 500 |
| Total current and long-term liabilities | $5,112 | $7,075 | |
| Stockholders’ equity | |||
| Series B Preferred Stock, par value $0.00001; 10,000,000 authorized, issued convertible preferred stock 1,600,000 as of September 30, 2025, and December 31, 2024 | 3.8 | $7,435 | $7,435 |
| Series A, Super Voting Preferred Stock - 20,000 shares (1,000 votes per share) | - | - | |
| Common stock, par value $0.00001; 2,000,000,000 authorized, 4,443,788 and 22,759 shares issued and outstanding as of September 30, 2025, and December 31, 2024, respectively | 11 | - | |
| Equity to be issued | 3,000 | - | |
| Additional paid-in capital | 36,818 | 21,022 | |
| Noncontrolling interest | (18) | - | |
| Accumulated deficit | (38,520) | (33,571) | |
| Total stockholders’ equity / (deficit) | 8,726 | (5,114) | |
| Total liabilities and stockholders’ equity | $13,838 | $1,961 | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.